Genomic test to rule out obstructive CAD may reduce need for more invasive diagnostics
Nearly $7 billion is spent each year in the U.S. on diagnostic testing of the estimated three million people with symptoms of obstructive coronary artery disease (CAD). A new blood test that detects specific genes activated ...
Mar 10, 2014
0
0